Table 2 Canonical pathways represented among the top 10% of decreased and increased methylated genes from differentially methylated regions in germinoma relative to yolk sac tumours (p-values < 0.01)
IPA pathway | Genes | p-value |
|---|---|---|
Decreased methylation in germinomaa compared to YST | ||
TWEAK signalling | TRAF3, TRAF2, TNFSF12, CASP8, CASP7, TRAF1 | 0.0001 |
Cardiac hypertrophy signalling | ADCY3, RHOT2, HAND1, ADRB3, PIK3R3, NKX2–5, PLCD3, CACNA1E, GNAO1, PRKACA, GNB2, IGF1R, PIK3CD, GNB1L, FNBP1 | 0.0001 |
Tec kinase signalling | PTK2, PIK3R3, TNFSF12, GNAO1, RHOT2, GNB2, PIK3CD, JAK3, GNB1L, TNF, FNBP1, PRKCZ | 0.0001 |
Sphingosine-1-phosphate signalling | PTK2, PIK3R3, PLCD3, PDGFA, ADCY3, RHOT2, PIK3CD, CASP8, FNBP1, CASP7 | 0.0002 |
Cytotoxic T lymphocyte-mediated apoptosis of target cells | CD247, B2M, HLA-A, CASP8, CASP7 | 0.0004 |
Role of NFAT in cardiac hypertrophy | PIK3R3, PLCD3, NKX2–5, HDAC7, ADCY3, GNB2, PRKACA, IGF1R, HAND1, PIK3CD, GNB1L, PRKCZ | 0.0004 |
Molecular mechanisms of cancer | RAPGEF1, RHOT2, ADCY3, PRKCZ, PIK3R3, PTK2, NF1, CDK20, GNAO1, E2F1, PRKACA, PIK3CD, CASP8, JAK3, NOTCH1, FNBP1, CASP7, LRP1 | 0.001 |
NF-κB signalling | PIK3R3, TRAF3, TRAF2, PRKACA, IGF1R, PIK3CD, LTBR, CASP8, TNFRSF1B, TNF, PRKCZ | 0.001 |
Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis | TRAF3, PDGFA, PRKCZ, PIK3R3, PLCD3, TRAF2, APC2, GNAO1, PIK3CD, LTBR, SOST, TNFRSF1B, TNF, LRP1, TRAF1 | 0.001 |
RAR activation | PIK3R3, PRMT2, CSK, NR2F2, ADCY3, PRKACA, PIK3CD, NCOR2, PML, PRKCZ, SMARCA4 | 0.001 |
Huntington’s disease signalling | SDHA, PRKCZ, PIK3R3, DNAJC5, HDAC7, GNB2, IGF1R, VAMP3, PIK3CD, NCOR2, CASP8, GNB1L, CASP7 | 0.001 |
Small-cell lung cancer signalling | PTK2, PIK3R3, TRAF3, TRAF2, E2F1, PIK3CD, TRAF1 | 0.001 |
Type I diabetes mellitus signalling | CD247, CD28, TRAF2, HLA-A, GAD1, CASP8, TNFRSF1B, TNF | 0.002 |
CXCR4 signalling | PTK2, PIK3R3, GNAO1, ADCY3, RHOT2, GNB2, PIK3CD, GNB1L, FNBP1, PRKCZ | 0.002 |
Lymphotoxin β-receptor signalling | PIK3R3, TRAF3, TRAF2, PIK3CD, LTBR, TRAF1 | 0.002 |
Death receptor signalling | TRAF2, TNFSF12, LMNA, CASP8, TNFRSF1B, TNF, CASP7 | 0.002 |
Thrombin signalling | PTK2, PIK3R3, PLCD3, GNAO1, ADCY3, RHOT2, GNB2, PIK3CD, GNB1L, FNBP1, PRKCZ | 0.002 |
Myc-mediated apoptosis signalling | PIK3R3, YWHAG, IGF1R, PIK3CD, CASP8, PRKCZ | 0.002 |
TNFR2 signalling | TRAF2, TNFRSF1B, TNF, TRAF1 | 0.003 |
Colorectal cancer metastasis signalling | PIK3R3, GRK2, ADCY3, RHOT2, GNB2, PRKACA, PIK3CD, JAK3, GNB1L, TNF, FNBP1, LRP1 | 0.004 |
CREB signalling in neurons | PIK3R3, PLCD3, GRM3, GNAO1, ADCY3, GNB2, PRKACA, PIK3CD, GNB1L, PRKCZ | 0.004 |
Relaxin signalling | PIK3R3, PDE9A, GNAO1, ADCY3, GNB2, PRKACA, PIK3CD, GNB1L, PRKCZ | 0.004 |
Gαq signalling | PIK3R3, GRK2, CSK, RHOT2, GNB2, PIK3CD, GNB1L, FNBP1, PRKCZ | 0.004 |
CD40 signalling | PIK3R3, TRAF3, TRAF2, PIK3CD, JAK3, TRAF1 | 0.004 |
Glioblastoma multiforme signalling | PIK3R3, PLCD3, NF1, PDGFA, E2F1, RHOT2, IGF1R, PIK3CD, FNBP1 | 0.005 |
IGF-1 signalling | PTK2, PIK3R3, YWHAG, PRKACA, IGF1R, PIK3CD, PRKCZ | 0.005 |
P2Y purigenic receptor signalling pathway | PIK3R3, PLCD3, ADCY3, GNB2, PRKACA, PIK3CD, GNB1L, PRKCZ | 0.005 |
Antigen presentation pathway | B2M, PSMB9, HLA-A, TAP1 | 0.006 |
Cardiac β-adrenergic Signalling | CACNA1E, GRK2, PDE9A, PPP1R3C, ADCY3, GNB2, PRKACA, GNB1L | 0.006 |
Induction of apoptosis by HIV1 | TRAF2, CASP8, TNFRSF1B, TNF, TRAF1 | 0.007 |
Role of PKR in interferon induction and antiviral response | TRAF3, TRAF2, CASP8, TNF | 0.008 |
Increased methylation in germinoma relative to YST | ||
Axonal guidance signalling | NTNG1, EFNB2, SRGAP3, BMP4, GLIS1, ARHGEF7, GNA12, C9orf3, ADAM19, PFN2, HHIP, KLB, GNG7, PRKCB | 0.0005 |
Signalling by Rho family GTPases | MAP3K9, CDH1, GNA12, ARHGEF7, PIP4K2B, ARHGEF18, ARHGEF3, KLB, GNG7 | 0.002 |
Breast cancer regulation by stathmin1 | CAMK1D, ARHGEF7, ARHGEF18, ITPR1, ARHGEF3, KLB, GNG7, PRKCB | 0.002 |
RhoGDI signalling | CDH1, GNA12, ARHGEF7, PIP4K2B, ARHGEF18, ARHGEF3, GNG7 | 0.003 |
TR/RXR activation | F10, PDE3B, PFKP, THRB, KLB | 0.004 |
Coagulation system | F10, F3, SERPINF2 | 0.006 |
Thrombin signalling | CAMK1D, GNA12, ITPR1, ARHGEF3, KLB, GNG7, PRKCB | 0.007 |
Guanosine nucleotides degradation III | NT5C2, ACPP | 0.007 |
Relaxin signalling | PDE3B, GNA12, PDE4D, NPR2, KLB, GNG7 | 0.007 |
Urate biosynthesis/inosine 5’-phosphate degradation | NT5C2, ACPP | 0.009 |